InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Longitude Capital Partners III, LLC. Officer active across 3 companies, notably Talaris Therapeutics, Inc.. In total, 8 disclosures have been logged. Total volume traded: €13m. The latest transaction was filed on 27 April 2022 — J. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
0175,000 shares0
Common Stock
SEC:0000899243-22-016052:0·
€5m1,355,000 shares@ €3.4184100.0% of flow
Common Stock
SEC:0000899243-22-015325:0·
Ideal exit: 14 Jan 2023 (T+270)
€4m175,000 shares@ €23.94921.2% of flow
Common Stock
SEC:0000899243-22-004271:0·
Ideal exit: 30 Oct 2022 (T+270)
€4m175,000 shares@ €23.94942.4% of flow
Common Stock
SEC:0000899243-22-004271·
Ideal exit: 30 Oct 2022 (T+270)
€6m487,451 shares@ €11.656557.6% of flow
Common Stock
SEC:0000899243-22-003502·
€6m487,451 shares@ €11.656528.8% of flow
Common Stock
SEC:0000899243-22-003502:0·
2,985,775 shares
Common Stock
SEC:0000899243-21-019166·
2,985,775 shares
Common Stock
SEC:0000899243-21-019166:0·
8 of 8 declarations
About Longitude Capital Partners III, LLC
Longitude Capital Partners III, LLC is a director and insider, primarily involved with Talaris Therapeutics, Inc.
